Nanotechnology has been used in many medical applications now from diagnosis to treatment and monitoring the patients over a period of time, however for diagnosis and treatment of rheumatoid arthritis a research program on nanotechnology is being funded. The program is being funded by European Commission and the research program is jointly carried out by a consortium of 15 European partners.
The consortium will work on the project NanoDiaRA “Development of Novel Nanotechnology Based Diagnosed Systems for Rheumatoid Arthritis and Osteoarthritis” for the next four years. Researchers will develop diagnostic tools for early detection of rheumatoid arthritis and osteoarthritis. Research team will also look for all possible treatment options for arthritis using nanotechnology devices and simultaneously the project will also focus on all socio legal aspects of using nanotechnology for medicine.
The project, which was started in February 2010 has recently completed six month and a meeting was recently held at Bad Neuenahr-Ahrweiler for reviewing the project status. All the consortium partners presented their progress and discussed various issues and hurdles including administrative and financial issues.
The action plan and milestones for the coming six months were also discussed and constitutes for different project groups. Consortium and European Commission also discussed the research output and licensing the output to the commercial groups so that the actual benefit of the research reaches masses as early as possible.